Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients

被引:30
作者
Yang, L. [1 ]
Tao, J. [1 ]
Tang, X. [2 ]
Wang, Y. [1 ]
He, X. [1 ]
Xu, G. [1 ]
Ren, Y. [1 ]
Tu, Y. [1 ]
机构
[1] Huazhong Univ Sci & Technol, Affiliated Union Hosp, Tongji Med Coll, Dept Dermatol, Wuhan 430074, Hubei Province, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Div Rheumatol, Hong Kong, Hong Kong, Peoples R China
基金
中国国家自然科学基金;
关键词
CORONARY-HEART-DISEASE; ACCELERATED ATHEROSCLEROSIS; ARTERY; WOMEN; STROKE;
D O I
10.1111/j.1468-3083.2011.04211.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background It has become clear that the morbidity and mortality of patients with lupus and cardiovascular disease (CVD) have substantially increased. Therefore, we designed a retrospective casecontrol study to assess the prevalence of traditional and lupus-specific risk factors for CVD in Chinese systemic lupus erythematosus (SLE) patients. Objective To identify the prevalence and correlation of conventional and lupus-specific risk factors for CVD in Chinese SLE patients. Methods One hundred and thirty-nine patients with SLE were enrolled in the study. They were compared with 139 age and gender-matched controls, who had no history of SLE or CVD. Among 139 SLE patients, there were 38 with CVD. We compared them with 38 SLE patients without CVD, matching for disease duration and age. Data regarding classic and lupus-specific risk factors were assessed between the two groups. Results Hypertension, serum creatinine and diabetes mellitus were more prevalent among SLE than the controls (P < 0.05). The patients with SLE were more likely to have elevated total, low-density lipoprotein cholesterol and triglyceride levels than the controls (P < 0.001). However, high-density lipoprotein levels in SLE patients were lower than that in controls (P = 0.019). After being compared with SLE patients without CVD, the patients with both SLE and CVD were more likely to have elevated serum creatinine, proteinuria, the presence of anti-Sm antibody and decreased complement 4 (C4) levels (P < 0.05). Moreover, the patients with both diseases were less likely to be treated with hydroxychloroquine (P < 0.05). In multivariable analysis, elevated serum creatinine, proteinuria, decreased C4 levels, the presence of anti-Sm antibody and the lack of using hydroxychloroquine were independent risk factors for CVD (P < 0.05). Conclusions We are able to identify some conventional and lupus-specific risk factors for CVD in Chinese SLE patients.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 27 条
[1]  
Anderson E, 2008, J RHEUMATOL, V35, P819
[2]   Premature coronary-artery atherosclerosis in systemic lupus erythematosus [J].
Asanuma, Y ;
Oeser, A ;
Shintani, AK ;
Turner, E ;
Olsen, N ;
Fazio, S ;
Linton, MF ;
Raggi, P ;
Stein, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (25) :2407-2415
[3]  
BORBA EF, 1994, J RHEUMATOL, V21, P220
[4]   Risk factors for coronary heart disease in women with systemic lupus erythematosus -: The Toronto Risk Factor Study [J].
Bruce, IN ;
Urowitz, MB ;
Gladman, DD ;
Ibañez, D ;
Steiner, G .
ARTHRITIS AND RHEUMATISM, 2003, 48 (11) :3159-3167
[5]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[6]   Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus [J].
Doria, A ;
Shoenfeld, Y ;
Wu, R ;
Gambari, PF ;
Puato, M ;
Ghirardello, A ;
Gilburd, B ;
Corbanese, S ;
Patnaik, M ;
Zampieri, S ;
Peter, JB ;
Favaretto, E ;
Iaccarino, L ;
Sherer, Y ;
Todesco, S ;
Pauletto, P .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (11) :1071-1077
[7]  
Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO
[8]  
2-I
[9]   The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus:: what has been changed? [J].
Feletar, M ;
Ibañez, D ;
Urowitz, MB ;
Gladman, DD .
ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :2067-2069
[10]   Systemic lupus erythematosus in three ethnic groups -: XVI.: Association of hydroxychloroquine use with reduced risk of damage accrual [J].
Fessler, BJ ;
Alarcón, GS ;
McGwin, G ;
Roseman, J ;
Bastian, HM ;
Friedman, AW ;
Baethge, BA ;
Vilá, L ;
Reveille, JD .
ARTHRITIS AND RHEUMATISM, 2005, 52 (05) :1473-1480